Literature DB >> 9628929

Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.

S F Ding1, J Noronha, S Joshi.   

Abstract

Retroviral vectors were engineered to express either sense (MoTiN-TRPsie+) or sense and antisense (MoTN-TRPsie+/-) RNAs containing the human immunodeficiency virus type-1 (HIV-1) trans -activation response (TAR) element and the extended packaging (Psie) signal. The Psie signal includes the dimer linkage structure (DLS) and the Rev response element (RRE). Amphotropic vector particles were used to transduce a human CD4+ T-lymphoid (MT4) cell line. Stable transductants were then tested for sense and antisense RNA production and susceptibility to HIV-1 infection. HIV-1 production was significantly decreased in cells transduced with MoTiN-TRPsie+ and MoTN-TRPsie+/-vectors. Efficient packaging of sense and most remarkably of antisense RNA was observed within the virus progeny. Infectivity of this virus was significantly decreased in both cases, suggesting that the interfering RNAs were co-packaged with HIV-1 RNA. Vector transduction was not expected to occur and was not observed. Inhibition of HIV-1 replication was also demonstrated in human peripheral blood lymphocytes transduced with retroviral vectors expressing antisense RNA. These results suggest that (i) both sense and antisense RNAs were co-packaged with HIV-1 RNA, (ii) the co-packaged sense and antisense RNAs inhibited virus infectivity and (iii) the co-packaged sense and antisense RNAs were not transduced. Sense and antisense RNA-based strategies may also be used to co-package other interfering RNAs (e.g. ribozymes) to cleave HIV-1 virion RNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628929      PMCID: PMC147669          DOI: 10.1093/nar/26.13.3270

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

Authors:  B A Sullenger; T R Cech
Journal:  Science       Date:  1993-12-03       Impact factor: 47.728

2.  Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.

Authors:  G Nasioulas; A S Zolotukhin; C Tabernero; L Solomin; C P Cunningham; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

3.  Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.

Authors:  I Bahner; K Kearns; Q L Hao; E M Smogorzewska; D B Kohn
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Comparative analysis of five highly conserved target sites within the HIV-1 RNA for their susceptibility to hammerhead ribozyme-mediated cleavage in vitro and in vivo.

Authors:  A Ramezani; S Joshi
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1996

5.  Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.

Authors:  D Bevec; B Volc-Platzer; K Zimmermann; M Dobrovnik; J Hauber; G Veres; E Böhnlein
Journal:  Hum Gene Ther       Date:  1994-02       Impact factor: 5.695

6.  Mode of dimerization of HIV-1 genomic RNA.

Authors:  G Awang; D Sen
Journal:  Biochemistry       Date:  1993-10-26       Impact factor: 3.162

7.  A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression.

Authors:  D A Mann; I Mikaélian; R W Zemmel; S M Green; A D Lowe; T Kimura; M Singh; P J Butler; M J Gait; J Karn
Journal:  J Mol Biol       Date:  1994-08-12       Impact factor: 5.469

8.  The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.

Authors:  S E Liem; A Ramezani; X Li; S Joshi
Journal:  Hum Gene Ther       Date:  1993-10       Impact factor: 5.695

9.  Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s).

Authors:  H Cohli; B Fan; R L Joshi; A Ramezani; X Li; S Joshi
Journal:  Antisense Res Dev       Date:  1994

10.  Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.

Authors:  J H Richardson; L A Child; A M Lever
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  4 in total

1.  HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.

Authors:  Lingbing Zeng; Vicente Planelles; Ziye Sui; Suzanne Gartner; Sanjay B Maggirwar; Stephen Dewhurst; Linbai Ye; Vivek R Nerurkar; Richard Yanagihara; Yuanan Lu
Journal:  J Gene Med       Date:  2006-01       Impact factor: 4.565

2.  Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.

Authors:  H W Wang; D Cole; W Z Jiang; H T Jin; N Fu; Z L Chen; N Y Jin
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

3.  An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication.

Authors:  D S An; K Morizono; Q X Li; S H Mao; S Lu; I S Chen
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 4.  Molecular strategies to inhibit HIV-1 replication.

Authors:  Morten Hjuler Nielsen; Finn Skou Pedersen; Jørgen Kjems
Journal:  Retrovirology       Date:  2005-02-16       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.